The latest data point in Q3'26 shows SG&A Expenses at 2.96B USD, while R&D Expenses remain at zero with no data available for this period. From Q4'23 to Q3'26, SG&A Expenses exhibited a generally upward trend with moderate volatility, rising from 2.80B USD to a peak of 3.02B USD in Q1'26 before slightly declining to 2.96B USD, representing an overall increase of approximately 5.8% across the nine-quarter period.